Proteomics technologies for biomarker discovery in multiple sclerosis.

Area of Science:

• Neuroimmunology
• Proteomics
• Biomarker Discovery

Background:

• Multiple sclerosis (MS) is a disabling inflammatory and neurodegenerative condition impacting young adults.
• There is a significant need for biomarkers to understand MS pathology, prognosis, and treatment efficacy.

Purpose of the Study:

• To review the current state of mass spectrometry-based proteomics for multiple sclerosis biomarker research.
• To identify challenges and future directions in this field.

Main Methods:

• Review of current literature on mass spectrometry-based proteomics in multiple sclerosis.
• Analysis of technological advancements and their application in biomarker identification.

Main Results:

• Mass spectrometry-based proteomics is a rapidly evolving technology with potential for MS biomarker development.
• Several bottlenecks exist in the current research, including data standardization and validation.

Conclusions:

• Proteomics holds promise for advancing multiple sclerosis biomarker discovery.
• Overcoming current limitations is essential for realizing the full potential of this technology in clinical applications.